Maharashtra FDA concludes Vimal ad probe against three actors
- Maharashtra FDA has concluded proceedings against Shah Rukh Khan, Ajay Devgn, and Tiger Shroff.
- The investigation identified breaches related to alleged surrogate advertising for Vimal pan masala.
- Ajay Devgn has filed a petition in the Bombay High Court to contest the FDA notice.
- The case is set for adjudication before the joint commissioner starting next week.
- Shah Rukh Khan is currently in London preparing for his upcoming film King.
The Maharashtra Food and Drug Administration has concluded its formal investigation into actors Shah Rukh Khan, Ajur Devgn, and Tiger Shroff regarding their advertisements for Vimal products. The agency's assistant commissioner finished the probe after the stars requested additional time to submit their replies to the earlier notices.
The FDA chief confirmed that the investigation is complete and has identified specific regulatory breaches by the actors. The matter is now pending a formal quasi-judicial adjudication process.
Ajay Devgn challenges FDA notice in Bombay High Court
Actor Ajay Devgn has approached the Bombay High Court to contest the notice served by the Maharashtra FDA concerning his pan masala advertisements. He submitted a formal petition to the court to contest the regulatory action.
The legal challenge specifically addresses the FDA notice concerning the actor's involvement in Vimal Elaichi campaigns. This filing occurs as the agency prepares to move the case forward despite the ongoing court proceedings.
Allegations of surrogate advertising for Vimal Elaichi
The Maharashtra FDA alleges that the advertisements for Vimal Elaichi serve as surrogate promotions for Vimal Pan Masala. The state has strictly banned the distribution of the chewable Vimal Pan Masala product.
The FDA issued notices to Shah Rukh Khan, Ajur Devgn, and Tiger Shroff claiming the campaigns function as advertisements for the prohibited items.
Adjudication process before the joint commissioner
The case will move to adjudication before the joint commissioner by the following week. This quasi-judicial process allows regulators to review evidence and determine if laws were violated. It permits penalties for non-criminal offences without the need for lengthy court trials.
The FDA will continue its proceedings against the actors before the joint commissioner despite the ongoing court challenge from Ajay Devgn.
Shah Rukh Khan's upcoming film King
Shah Rukh Khan is preparing for the release of his upcoming film King, which hits theatres on 24 December 2026. The first song from the production is scheduled for release on 2 November 2026, marking the actor's 61st birthday.
The actor will be in London to shoot the song on his birthday instead of celebrating outside his Mumbai residence, Mannat. Shah Rukh Khan said Arijit Singh is the singer for the main track and is taking additional time to perfect the song.
The ensemble cast features Deepika Padukone, Anil Kapoor, Abhishek Bachchan, and Suhana Khan. Other actors include Rani Mukerji, Jackie Shroff, Arshad Warsi, Abhay Verma, and Kareena Kapoor, who appears in a special dance number.
Frequently Asked Questions
- Maharashtra FDA completes proceedings against Shah Rukh Khan, Ajay Devgn and Tiger Shroff over pan masala ads; Tukaram Mundhe says, 'Assistant commissioner found that they violated the state’s rules' (timesofindia.indiatimes.com)
- First King Song To Be Out On Shah Rukh Khan's 61st Birthday: Report (ndtv.com)
- Actor Ajay Devgn moves Bombay High Court against FDA notice over Vimal Elaichi ads (m.economictimes.com)
- Tiger Shroff (Wikipedia — background) (en.wikipedia.org)
Add NewsPulse Time as a preferred source on Google